Newcells Biotech has announced leadership changes, with Dr. Valeria Chichagova promoted to Director of Technology, Dr. Colin Brown appointed as Chief Scientific Officer, and Professor Lyle Armstrong taking on the role of Scientific Advisor. The company has also made new commercial appointments in the US to support its global customer network. These changes come as a response to increased market demand for new approach methods in drug discovery workflows. The new leadership team will drive innovation, enhance existing models, and boost research and development efficiency. Newcells Biotech aims to accelerate clinical translation in drug discovery and bring innovative new medicines to market faster.
Source link
Newcells Biotech strengthens executive and US team with key appointments
